Turk J Haematol 2020 Jan 31
Performance of Positron Emission Tomography-Computed Tomography and Bone Marrow Biopsy in Detecting Bone Marrow Infiltration in Lymphoma Cases
Büyüksimsek M, Kolsuz I, Yetisir AE, Tohumcuoglu M, Ogul A, Mirili C, Paydas S, Güney IB
Bone marrow infiltration (BMI) affects the stage of lymphoma, survey, and treatment. We aimed to evaluate the performance of bone marrow biopsy (BMB) ...
Read More
Source: PubMed
J Community Hosp Intern Med Perspect
An unusual case of proton pump inhibitor induced hyperchromograninemia.
Adu-Gyamfi KO, Gyamfi R, Patri S
Objective: To describe an unusual case of symptomatic hyperchromograninemia associated with proton pump inhibitor (PPI) use. Case Summary: A 55-year-o ...
Read More
Source: PubMed
Cardiovasc Hematol Disord Drug Targets 2020 Jan 29
Co-existence of follicular lymphoma in the lymph node with High-grade B cell lymphoma in the bone marrow of a patient presenting with spontaneous tumor lysis syndrome.
Giatra C, Sykaras AG, Constantinou F, Gennimata V, Sampaziotis D, Geladari E, Kounatidis D, Vallianou NG
A significant percentage of B-cell lymphomas are characterized by bone marrow involvement (BMI) at diagnosis. In most cases, there is concordance betw ...
Read More
Source: PubMed
Eur. J. Haematol. 2020 Jan 30
Efficacy and safety of pixantrone for the treatment of multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphomas.
Sancho JM, Navarro B, Soler Campos JA, Pérez de Oteyza J, de Barrenetxea Lekue C, Bregni M, Grasso Cicala S, Spione M, Mombiedro C, Soler B, Zinzani PL
Few treatment options exist for patients with relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (NHL) who fail first- and second-line therapies. P ...
Read More
Source: PubMed
Hematol Oncol 2020 Jan 28
Mucosal dysbiosis in patients with gastrointestinal follicular lymphoma.
Zeze K, Hirano A, Torisu T, Esaki M, Shibata H, Moriyama T, Umeno J, Fujioka S, Okamoto Y, Fuyuno Y, Matsuno Y, Kitazono T
Because the pathogenesis of gastrointestinal follicular lymphoma (GI-FL) remains unclear, no standardized treatment strategy has been established. Of ...
Read More
Source: PubMed
Turk J Haematol 2020 Jan 31
Performance of Positron Emission Tomography-Computed Tomography and Bone Marrow Biopsy in Detecting Bone Marrow Infiltration in Lymphoma Cases
Büyüksimsek M, Kolsuz I, Yetisir AE, Tohumcuoglu M, Ogul A, Mirili C, Paydas S, Güney IB
Bone marrow infiltration (BMI) affects the stage of lymphoma, survey, and treatment. We aimed to evaluate the performance of bone marrow biopsy (BMB) ...
Read More
Source: PubMed
J Community Hosp Intern Med Perspect
An unusual case of proton pump inhibitor induced hyperchromograninemia.
Adu-Gyamfi KO, Gyamfi R, Patri S
Objective: To describe an unusual case of symptomatic hyperchromograninemia associated with proton pump inhibitor (PPI) use. Case Summary: A 55-year-o ...
Read More
Source: PubMed
Cardiovasc Hematol Disord Drug Targets 2020 Jan 29
Co-existence of follicular lymphoma in the lymph node with High-grade B cell lymphoma in the bone marrow of a patient presenting with spontaneous tumor lysis syndrome.
Giatra C, Sykaras AG, Constantinou F, Gennimata V, Sampaziotis D, Geladari E, Kounatidis D, Vallianou NG
A significant percentage of B-cell lymphomas are characterized by bone marrow involvement (BMI) at diagnosis. In most cases, there is concordance betw ...
Read More
Source: PubMed
Eur. J. Haematol. 2020 Jan 30
Efficacy and safety of pixantrone for the treatment of multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphomas.
Sancho JM, Navarro B, Soler Campos JA, Pérez de Oteyza J, de Barrenetxea Lekue C, Bregni M, Grasso Cicala S, Spione M, Mombiedro C, Soler B, Zinzani PL
Few treatment options exist for patients with relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (NHL) who fail first- and second-line therapies. P ...
Read More
Source: PubMed
Hematol Oncol 2020 Jan 28
Mucosal dysbiosis in patients with gastrointestinal follicular lymphoma.
Zeze K, Hirano A, Torisu T, Esaki M, Shibata H, Moriyama T, Umeno J, Fujioka S, Okamoto Y, Fuyuno Y, Matsuno Y, Kitazono T
Because the pathogenesis of gastrointestinal follicular lymphoma (GI-FL) remains unclear, no standardized treatment strategy has been established. Of ...
Read More
Source: PubMed
Turk J Haematol 2020 Jan 31
Performance of Positron Emission Tomography-Computed Tomography and Bone Marrow Biopsy in Detecting Bone Marrow Infiltration in Lymphoma Cases
Büyüksimsek M, Kolsuz I, Yetisir AE, Tohumcuoglu M, Ogul A, Mirili C, Paydas S, Güney IB
Bone marrow infiltration (BMI) affects the stage of lymphoma, survey, and treatment. We aimed to evaluate the performance of bone marrow biopsy (BMB) ...
Read More
Source: PubMed
J Community Hosp Intern Med Perspect
An unusual case of proton pump inhibitor induced hyperchromograninemia.
Adu-Gyamfi KO, Gyamfi R, Patri S
Objective: To describe an unusual case of symptomatic hyperchromograninemia associated with proton pump inhibitor (PPI) use. Case Summary: A 55-year-o ...
Read More
Source: PubMed
Cardiovasc Hematol Disord Drug Targets 2020 Jan 29
Co-existence of follicular lymphoma in the lymph node with High-grade B cell lymphoma in the bone marrow of a patient presenting with spontaneous tumor lysis syndrome.
Giatra C, Sykaras AG, Constantinou F, Gennimata V, Sampaziotis D, Geladari E, Kounatidis D, Vallianou NG
A significant percentage of B-cell lymphomas are characterized by bone marrow involvement (BMI) at diagnosis. In most cases, there is concordance betw ...
Read More
Source: PubMed
Eur. J. Haematol. 2020 Jan 30
Efficacy and safety of pixantrone for the treatment of multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphomas.
Sancho JM, Navarro B, Soler Campos JA, Pérez de Oteyza J, de Barrenetxea Lekue C, Bregni M, Grasso Cicala S, Spione M, Mombiedro C, Soler B, Zinzani PL
Few treatment options exist for patients with relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (NHL) who fail first- and second-line therapies. P ...
Read More
Source: PubMed
Hematol Oncol 2020 Jan 28
Mucosal dysbiosis in patients with gastrointestinal follicular lymphoma.
Zeze K, Hirano A, Torisu T, Esaki M, Shibata H, Moriyama T, Umeno J, Fujioka S, Okamoto Y, Fuyuno Y, Matsuno Y, Kitazono T
Because the pathogenesis of gastrointestinal follicular lymphoma (GI-FL) remains unclear, no standardized treatment strategy has been established. Of ...
Read More
Source: PubMed
Turk J Haematol 2020 Jan 31
Performance of Positron Emission Tomography-Computed Tomography and Bone Marrow Biopsy in Detecting Bone Marrow Infiltration in Lymphoma Cases
Büyüksimsek M, Kolsuz I, Yetisir AE, Tohumcuoglu M, Ogul A, Mirili C, Paydas S, Güney IB
Bone marrow infiltration (BMI) affects the stage of lymphoma, survey, and treatment. We aimed to evaluate the performance of bone marrow biopsy (BMB) ...
Read More
Source: PubMed
J Community Hosp Intern Med Perspect
An unusual case of proton pump inhibitor induced hyperchromograninemia.
Adu-Gyamfi KO, Gyamfi R, Patri S
Objective: To describe an unusual case of symptomatic hyperchromograninemia associated with proton pump inhibitor (PPI) use. Case Summary: A 55-year-o ...
Read More
Source: PubMed
Cardiovasc Hematol Disord Drug Targets 2020 Jan 29
Co-existence of follicular lymphoma in the lymph node with High-grade B cell lymphoma in the bone marrow of a patient presenting with spontaneous tumor lysis syndrome.
Giatra C, Sykaras AG, Constantinou F, Gennimata V, Sampaziotis D, Geladari E, Kounatidis D, Vallianou NG
A significant percentage of B-cell lymphomas are characterized by bone marrow involvement (BMI) at diagnosis. In most cases, there is concordance betw ...
Read More
Source: PubMed
Eur. J. Haematol. 2020 Jan 30
Efficacy and safety of pixantrone for the treatment of multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphomas.
Sancho JM, Navarro B, Soler Campos JA, Pérez de Oteyza J, de Barrenetxea Lekue C, Bregni M, Grasso Cicala S, Spione M, Mombiedro C, Soler B, Zinzani PL
Few treatment options exist for patients with relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (NHL) who fail first- and second-line therapies. P ...
Read More
Source: PubMed
Hematol Oncol 2020 Jan 28
Mucosal dysbiosis in patients with gastrointestinal follicular lymphoma.
Zeze K, Hirano A, Torisu T, Esaki M, Shibata H, Moriyama T, Umeno J, Fujioka S, Okamoto Y, Fuyuno Y, Matsuno Y, Kitazono T
Because the pathogenesis of gastrointestinal follicular lymphoma (GI-FL) remains unclear, no standardized treatment strategy has been established. Of ...
Read More
Source: PubMed
